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Summary The analysis of transcriptomics data is able
to give an overview of cellular processes, but requires
sophisticated bioinformatics tools and methods to
identify the changes. Pathway analysis software, like
PathVisio, captures the information about biological
pathways from databases and brings this together
with the experimental data to enable visualization
and understanding of the underlying processes. Rett
syndrome is a rare disease, but still one of the most
abundant causes of intellectual disability in females.
Cause of this neurological disorder is mutation of
one single gene, the methyl-CpG-binding protein 2
(MECP2) gene. This gene is responsible for many steps
in neuronal development and function. Although the
genetic mutation and the clinical phenotype are well
described, the molecular pathways linking them are
not yet fully elucidated. In this study we demonstrate
a workflow for the analysis of transcriptomics data to
identify biological pathways and processes which are
changed in a Mecp2-/y mouse model.
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Neue Erkenntnisse zum Rett-Syndrom mit der
Signalweganalyse von Transkriptomdaten
Zusammenfassung Die Analyse von Transkriptom-
daten ist in der Lage, ein Gesamtbild der veränder-
ten zellulären Prozesse widerzugeben. Dafür bedarf
es aber spezieller bioinformatischer Methoden, um
diese Veränderungen sicher zu identifizieren. Mit ei-
ner Software, wie PathVisio z. B., wird auf eine Daten-
bank mit Informationen über biologische Stoffwech-
sel- und Signalwege zugegriffen und diese mit den
experimentell ermittelten Daten abgeglichen. Damit
können diese visualisiert und die zugrunde liegen-
den biologischen Prozesse besser verstanden werden.
Das Rett-Syndrom ist eine seltene Krankheit und eine
der häufigsten Ursachen für geistige Behinderung bei
Frauen. Die Ursache sind Mutationen im MECP2-Gen
(„methyl-CpG-binding protein 2“), einem wichtigen
epigenetischen Regulator in Nervenzellen. Zwar wur-
den die Mutationen und daraus resultierende klini-
sche Phänotypen gut beschrieben, doch besteht noch
kein umfassendes Verständnis der vernetzenden mo-
lekularen Prozesse. In der vorliegenden Studie stel-
len die Autoren einen Workflow für die Analyse von
Transkriptomdaten dar, mit dem sich die veränderten
biologischen Stoffwechsel- und Signalwege in einem
Mecp2-/y-Maus-Modell identifizieren lassen.
Schlüsselwörter Rett-Syndrom · Seltene Krankheit ·
Systembiologie · Pathway-Analyse · Bioinformatik
Introduction
Progress in biomedical methods today enables gen-
eration of vast amounts of molecular data, namely
transcriptomics data with up to 100,000 transcripts
which occur in a human cell. The current challenge
is to identify the needle of changed processes in
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Fig. 1 Demonstrationof howgeneontologyannotations lead to understandingof biological networks.ThegenesSlc27a, Lpl,
Rxrg, Acadl, Cpt2, andAcadvl aredifferentially expressed in interneurons.All of themexceptAcadvl contribute to theperoxisome
proliferator-activated receptor (PPAR) signalingpathwaywhich is therefore assumed tobechanged.Threeof thesegenes, Acadl,
Acadvl, andCpt2are also involved in fatty acidmetabolism. Theoverlappinggenesof thePPARsignalingpathwayand fatty acid
metabolismareAcadl andCpt2. Thenumber of direct connectionscanbeusedasan indicator howwell connected—how impor-
tant—aprocessor apathway is. Using this existing knowledge incombinationwithexperimental data, it is possible to analyze,
visualize, andunderstandanetworkof changedprocesses
the haystack of data, and to combine different types
of data. Pathway analysis combines these experi-
mental transcriptome data with structured existing
knowledge. Bioinformatics analysis and visualization
methods and tools allow explanation and proof of
whether and how a certain biological pathway is al-
tered as a consequence of the experiment, which may
be a mutation, drug application, nutrition, or disease.
One of the strengths of this approach is that it provides
a general picture of how the biological network is af-
fected without being biased by hypothesis. Instead of
hypothesis-driven experiments and data analysis, we
are speaking of data-driven approaches [1]. There are
databases for single entities like genes, transcripts,
proteins, and metabolites (e. g. Ensembl, NCBI,
MSeqDR, UniProt, ChEBI) [2], as well as reposito-
ries of structured biological knowledge like WikiPath-
ways.org [3], which is a curated database of biological
pathways. WikiPathways.org contains biological path-
ways of several species, namely metabolite–enzyme
interactions, gene signaling cascades, receptor–target
interactions, and disease-related pathways, and can
be used for reviewing and visualizing knowledge [4]
or data analysis (and visualization) [1, 5–7] (http://
wikipathways.tumblr.com/). Gene annotations, as
defined in gene ontology [8], give machine-readable
information about the cellular component in which
this gene is present (e. g., nucleus, mitochondria), the
molecular function (e. g., membrane-binding or es-
terase activity), and the biological process (e. g., neg-
ative regulation of neuronal differentiation). Single
genes can contribute to multiple processes and link
pathways with each other. Fig. 1 shows an example
how gene annotations lead to understanding of bio-
logical network changes, e. g., fatty acid metabolism
in MECP2-deficient mouse interneurons.
If a group of genes which have the same or linked
gene ontology annotation are up- or downregulated
together, we speak of term enrichment or overrepre-
sentation, which is measurable and gives information
about the functions, processes, and cellular compo-
nents that are changed. This approach is especially
useful for investigation of rare diseases and disorders
like Rett syndrome, where the genetic cause and the
clinical phenotypes are well known, but there are still
gaps in understanding how the biological pathways
are modified and lead to these phenotypes.
Rett syndrome is a rare disorder which was first
described by Andreas Rett [9] and affects about
1:10,000 females [10]. Typical symptoms are re-
gression and loss of acquired skills at the age of
6–18 months after a normal pre- and postnatal de-
velopment. Rett females are typically severely in-
tellectual disabled, hardly able to perform directed
movements (including gait and speech), although
stereotypic repetitive movements (“hand washing”)
are often observed. Typical additional symptoms are
abnormal cardiac and respiratory function, scolio-
sis, epilepsy, and sleep problems [11]. The cause of
this disorder is a mutation—de novo in almost all
cases—in the gene for methyl-CpG-binding protein 2
(MECP2), which is located on the X chromosome
[12]. Rett females are typically heterozygous while
hemizygous males are usually not viable. There are
about 200 different mutations known which lead to
Rett syndrome. These occur mostly in either the DNA
binding domain—a loss in specificity to recognize
and bind methylated DNA is already enough to lead
to Rett syndrome [13]—or the transcription repressor
binding domain.
The objective of this study is to present a bioinfor-
matics workflow to give an overview of changed bi-
ological pathways in Rett syndrome using transcrip-
tomics data. In this study we investigated the dif-
ferentially expressed genes and affected pathways in
four different primary neuronal cell types using pub-
lished (but not investigated to this extent) data from
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a Mecp2-/y mouse model originally published by Sug-
ino et al. [14].
Materials and methods
The data source
In the current study a previously published study from
Sugino et al. [14] was used. These authors investigated
a special mouse model which was bred from GFP-/
YFP-labeled transgenic G42 and TH line, crossed with
mice lacking functional Mecp2 and backcrossed with
C57BL/6. They selected male, 37–55-day-old, hemizy-
gous null (Mecp2-/y) or wildtype controls. Brain tis-
sue slices of the desired area were cut out and cell
sorting was performed: 1. layer 5 thick tufted pyra-
midal neurons (TTL5) in the motor cortex labeled
in YFPH line, 2. fast-spiking parvalbumin-positive in-
terneurons in the motor cortex labeled in the g42 line,
3. noradrenergic locus coeruleus neurons labeled in
the TH line, and 4. cerebellar Purkinje cells labeled
in the G42 line. Three samples, each from a different
animal, were taken for microarray analysis. After ex-
traction and preparation, the RNA was hybridized to
Affymetrix Mouse Genome 430 2.0 oligonucleotide ar-
rays (MOE430v2) (Affymetrix, Santa Clara, USA) [14].
This dataset was uploaded and published on ArrayEx-
press (E-GEOD-8720) [15].
Data quality control, pre-processing, and statistics
In ArrayAnalysis.org, namely the AffyQC and statis-
tics tool [16], the quality of the selected raw tran-
scriptomics data was controlled, the data were nor-
malized using GC-RMA, and statistically analyzed us-
ing an adapted t-test. Finally, a list of significantly
changed genes for each cell type (e. g., Purkinje cells
of Mecp2-/y vs. wild type) was obtained using a cutoff
of a ±0.5 log2-fold change and p ≤ 0.05.
Pathway analysis
For pathway analysis we used PathVisio (version 3.2.0)
[17]. The pathway repository used to perform path-
way statistics was WikiPathways [3], namely the cu-
rated collection of Mus musculus-specific pathways
(28.4.2016). Data integration for the variety of identi-
fiers requires use of BridgeDb identifier mapping ser-
vice [18]. To calculate z-score—an index represent-
ing whether and how much a pathway is changed if
pathway components are changed—and p-values, the
following logic was used: ((LogFC ≤ -0.5 OR LogFC ≥
0.5) AND p ≤ 0.05). The pathways which had z-score
>1.96, minimum number of changed genes >3, and
p ≤ 0.05 were considered as changed.
Gene ontology term enrichment analysis
Gene ontology term enrichment analysis was per-
formed using GO-Elite (version 1.2.5) [19]. We com-
pared the list of significantly changed genes versus
all investigated genes. The number of permuta-
tions for overrepresentation analysis was set to 2000,
z-score to >1.96, p ≤ 0.05, and minimum number of
changed genes ≥3. Only Ensembl annotations were
taken into the analysis, which means not considering
64 Affymetrix IDs out of 17,417 identifiers in the list
of all genes investigated. Results of this analysis were
visualized using Cytoscape (version 3.4.0) [20] and the
number of direct neighbors of a data node was used
as an indicator. The pathway and network analysis
workflow was described previously [1].
Results
The original study by Sugino et al. already indicated
that each of the four investigated subpopulations of
neuronal cells of a Mecp2-/y mouse model expresses
a different set of genes in comparison to wildtype,
and they found especially cell adhesion genes and
long genes (>20 kbp) to be overrepresented among
the changed genes. In the present study, the raw tran-
scriptomics data were reanalyzed using ArrayAnaly-
sis.org (the quality control, QC, report can be found
in the supplementary data). Finally, lists of differen-
tially expressed genes were extracted (supplementary
table 1) and pathway and gene ontology term enrich-
ment analysis was performed to reveal the biological
pathways changed in this model system. 258 genes
are differentially expressed in Purkinje cells, 850 in lo-
cus coeruleus neurons, 463 in TTL5, and 301 in fast-
spiking interneurons.
Pathway analysis
In each cell type there are different sets of pathways af-
fected (supplementary table 2). Fatty acid metabolism
(fatty acid oxidation, mitochondrial fatty acid beta-
oxidation, and adipogenesis) are the predominantly
changed pathways in fast-spiking interneurons of the
motor cortex (Fig. 1). The expression of Gcdh (glu-
taryl-coenzyme A dehydrogenase), Lpl (lipoprotein
lipase), Acadl (acyl-coenzyme A dehydrogenase, long
chain), Acadvl (acyl-coenzyme A dehydrogenase, very
long chain), and Slc25a20 (solute carrier family 25
[mitochondrial carnitine/acylcarnitine translocase],
member 20) is down, whereas the expression of Cpt2
(carnitine palmitoyltransferase 2) and Chkb (choline
kinase beta) is upregulated. In the locus coeruleus
neurons, glutathione and amino acid metabolism
is affected, in which the expression of glutathione-
producing enzymes is significantly downregulated
(Fig. 2). Gss (glutathione synthetase) and Gclm
(glutamate-cysteine ligase, modifier subunit), both
enzymes which are directly involved in the produc-
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Fig. 2 Pathwayvisualizationof changedglutathionepathway in locuscoeruleusneurons. Glutathionepathway is fromWikiPath-
ways (http://www.wikipathways.org/instance/WP164) supplementedwith theexperimental data. Blueboxes indicatedownregula-
tion, redupregulationof this geneandagreenmarker in thebox indicates that this change is significant (p≤0.05).Note that several
geneswhichcatalyze the reaction fromglutamate to glutathionearedownregulated
tion of glutathione out of glutamate, are significantly
downregulated. Supplementary table 2 gives a com-
plete overview of the changed biological pathways
in the four cell types of Mecp2-/y mice compared to
wildtype mice.
Gene ontology term enrichment analysis
Gene ontology in general gives a triplet of annotation
(information) for each gene: cell compartment (local-
ization), molecular function, and biological process in
which this gene is involved. Term enrichment anal-
ysis gives information about whether these terms are
over- or underrepresented for a certain dataset, and,
therefore, whether these biological processes, molec-
ular functions, or cellular compartments are espe-
cially affected. The connections between these single
changed processes were linked and visualized using
Cytoscape. The visualization of this network allows
determination of which differentially expressed genes
are interfering with different processes—and whether
they are linking several processes with one another.
The affected cellular compartment was mainly the
nucleus and nucleus-related processes like the DNA-
bending complex or regulation of histone modifica-
tion, except for the TTL5 (supplementary table 3).
Cell adhesion- and cytoskeleton-related processes
(e. g., actin filament, filopodium) are changed in all
cell types except for the fast-spiking interneurons.
Neurospecific functions (e. g., postsynaptic mem-
brane, neuron projection) were found to be changed
in all four cell types investigated.
Investigating molecular function, glutamate bind-
ing and glutamate receptor activity was changed in
Purkinje cells and TTL5; while ion flux-related recep-
tors, channels, and binding proteins changed in all
cell types (supplementary table 3). The specific ions
were mostly calcium and potassium, indicating neu-
ronal function and signal transduction. Receptor ac-
tivities for IGF, androgen, semaphorin, ephrin, β-tubu-
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Fig. 3 NetworkvisualizationofchangedprocessesinPurkinjecellsofMecp2-/y vs. wildtypeusingCytoscape[20]. Highlightedisthe
biological processofmetal ionbindingwith thegeneswhicharedifferentially expressed
lin, actin, clathrin, and steroid hormones were also
affected. Locus coeruleus neurons revealed a lot of
changed enzyme activity.
There are between 46 and 165 biological pro-
cesses changed for each cell type (supplementary
table 3). For Purkinje cells, the most changed pro-
cesses (highest z-score, indicating the chance that
there are enough differently expressed genes to affect
the whole process) are semicircular canal morphogen-
esis, regulation of cholesterol metabolic process, and
behavioral defense response. The network analysis re-
vealed the affected biological processes that are most
connected with other processes, which are metal ion
binding and intracellular signal transduction. Fig. 3
shows the visualization of changed processes in Purk-
inje cells and especially the genes/proteins annotated
with metal ion binding which are differentially ex-
pressed. Fig. 4 shows the changed processes for all
cell types. The high resolution images are available in
the supplementary material.
Locus coeruleus neurons: With the highest z-scores
are the processes sympathetic ganglion development,
self-proteolysis, and detection of temperature stimu-
lus. Network analysis showed negative regulation of
cell proliferation and regulation of neuron projection
to be the most connected processes.
TTL5: Behavioral defense response, labyrinthine
layer blood vessel development, pyrimidine-contain-
ing compound catabolic process, and negative regula-
tion of BMP signaling pathway are the biological pro-
cesses changed with the highest z-scores. The most
connected processes are regulation of ion transport
and regulation of neuron differentiation.
Fast-spiking interneurons: The highest z-scores
are glutamate binding, myelin sheath, regulation of
cholesterol metabolic process, and axon develop-
ment. The most connected processes are regulation
of neuron differentiation and regulation of cell pro-
jection organization.
Discussion
The present study is a data-driven approach to in-
vestigate the changes in gene expression and com-
bine the results with prior knowledge. The transcrip-
tomics data were obtained from a previously pub-
lished study by Sugino et al. [14] using four differ-
ent subpopulations of neuronal cells in a Mecp2-/y
mouse model. We reanalyzed the raw transcriptomics
data and applied pathway and gene ontology analy-
sis. The analysis confirmed the change of biological
processes and functions belonging to neuro-specific
metabolism: especially synapsis function [21] and glu-
tamate/glutathione metabolism [21–23] are affected
in Mecp2-/y mice, and a mismatch between excitatory
and inhibitory neuronal activities is observed [21, 24].
These are known to be changed in Rett syndrome (in
humans and in a mouse model) and contribute to
disorder development and etiology. New insights are
found by looking at the specific changes of individ-
ual cell types, indicating that for disorder develop-
ment and symptoms, the different neuronal cell pop-
ulations are differentially affected.
● Purkinje cells are GABAergic neurons. They are
inhibitory, highly connected (about 500 synapses
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Fig. 4 Network visualizationof changedprocesses inaPurkinje cells,b locuscoeruleusneurons,cTTL5,d fast-spiking interneu-
rons. High-resolution imagesof thesenetworksare in the supplementarydata
each), and contribute to motoric coordination.
Changes in ion transport and membrane trafficking
highly affects their function. For Rett syndrome, the
mismatch between inhibitory and excitatory neu-
ronal pathways are known contribute to disorder
development [24].
● Locus coeruleus neurons: the locus coeruleus is lo-
cated in the brainstem and is one of the main pro-
ducers of norepinephrine. It is furthermore related
to several neuronal functions like sleep/wake cycle,
posture and balance, and neuroplasticity, which are
indeed impaired in Rett females. It is also the center
which is affected in several other neurological dis-
orders like Parkinson’s disease. An impaired regula-
tion of cell proliferation (which may be a cause or a
consequence of changed amino acid pathway) and
affected neuronal differentiation affects its proper
function.
● TTL5: TTL5 are excitatory neurons and most im-
portant for information processing. They are the
neurons with the most extensive arborization and
connect the different cortical layers. Also here is
ion transport most relevant for neurological signal
transduction, and proper regulation of excitatory
and inhibitory signals is crucial for function.
● Fast-spiking interneurons: interneurons are in-
volved in positive and negative feedback mech-
anisms, they are able to transduce excitatory to
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inhibitory signals, and can create (or contribute)
to electric oscillations in neuronal networks. Fatty
acidmetabolismwas found to be affected especially
here (Fig. 1). The metabolomics study of Viola et al.
found different levels of certain phospholipids in
a Rett syndrome mouse model, but it is not clear
yet whether this is cause or consequence of reduced
cell growth [22].
The present study shows how pathway and gene on-
tology analysis tools can be used to find biological
processes of interest based on changes in gene ex-
pression. A more detailed investigation of the data
is necessary, especially to separate between up- and
downregulated processes, and to link them to their
specific function. Knowing the changed processes,
and the single genes and proteins behind these pro-
cesses, furthermore allows searching for specific drugs
which bind and modify these targets. We expect that
the application of these tools and methods is going to
improve not only research on Rett syndrome or other
neurological disorders, but will contribute to a better
understanding of neurological physiology in general.
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